XtalPi acquires Liverpool ChiroChem for innovation boost
06/13/25, 8:09 AM
Location
Industry
biotechnology
artificial intelligence
biotechnology
XtalPi announced its acquisition of Liverpool ChiroChem, enhancing its capabilities in chemical space exploration. This strategic move integrates LCC's chiral chemistry expertise into XtalPi's AI-driven platform. The acquisition aims to accelerate innovation in pharmaceuticals and materials science. By combining resources, the two companies intend to redefine chemical discovery processes.
Company Info
Location
Cambridge, Massachusetts, United States
Company info
XtalPi Holdings Limited (XtalPi, 2228.HK) was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries.
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Yh
Yh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ph
Ph • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more